Boyle, Rebecca

Boyle, Rebecca was paid $409K by Medicaid between Jun 2023 and Jul 2024, across 15 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.

33Billing provider infoBOYLE, REBECCA
COLUMBUS, OH 43204

33aNPI1316489800assigned 11/15/2016

33bProvider typeNurse Practitioner

28Total paid$409K

24GClaims4,754

24DCodes billed15

24AFirst – last monthJun 2023 – Jul 2024

Compared with peers

Next to other Nurse Practitioner providers in Ohio

Rank by total paid#23 of 168

Median peer was paid$9K

This provider vs. median46×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2023	599	$59K
2024incomplete	4,155	$350K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	54%	1,803	1,334	$220K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	21%	652	633	$84K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	13%	1,176	904	$53K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	5.8%	132	132	$24K
82075		2.7%	548	471	$11K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.8%	91	81	$7K
87529		<1%	43	43	$2K
87511		<1%	43	43	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	43	43	$1K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	43	43	$1K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	43	43	$1K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	43	43	$1K

3 more codes

87481		<1%	34	$878.97
86780		<1%	43	$424.99
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17	$141.18

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.